Michael W Rogers's Net Worth
$1.39 Million
Who is Michael W Rogers?
Michael W Rogers has an estimated net worth of $1.39 Million. This is based on reported shares across multiple companies, which include BG Medicine, Inc., pSivida LTD, Aerpio Pharmaceuticals, Inc., CORONADO BIOSCIENCES INC, ACORDA THERAPEUTICS INC, Akebia Therapeutics, Inc., Aravive, Inc., KERYX BIOPHARMACEUTICALS INC, and INDEVUS PHARMACEUTICALS INC.
SEC CIK
Michael W Rogers's CIK is 0001244159
Past Insider Trading and Trends
2018 was Michael W Rogers's most active year for acquiring shares with 13 total transactions. Michael W Rogers's most active month to acquire stocks was the month of May. 2008 was Michael W Rogers's most active year for disposing of shares, totalling 5 transactions. Michael W Rogers's most active month to dispose stocks was the month of March. 2017 saw Michael W Rogers paying a total of $1,611,533.00 for 365,506 shares, this is the most they've acquired in one year. In 2014 Michael W Rogers cashed out on 5,930 shares for a total of $196,843.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BG Medicine, Inc. No price found
EVP, CFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
pSivida LTD (EYPT) Snapshot price: $7.97
InvestorMichael W Rogers owns 119,167 units of Common Stock which is worth $949,760.99.acquired a total of 119,167 shares in pSivida LTD at a cost of $113,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
| +5.93% | 6.67K |
—
|
—
| 119.17K |
Jun 21
| |||
Form 4
| +800.00% | 100K |
$1.13 | $113,000.00 | 112.5K |
Nov 15
| |||
Form 4
|
∞
| 12.5K |
—
|
—
| 12.5K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aerpio Pharmaceuticals, Inc. (AADI) Snapshot price: $1.82
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CORONADO BIOSCIENCES INC (FBIO) Snapshot price: $1.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACORDA THERAPEUTICS INC (ACOR) No price found
Chief Financial OfficerMichael W Rogers owns 40,713 units of Common Stock. In the year 2013 Michael W Rogers filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| -2.31% | -964.00 |
$38.06 | -$36,689.17 | 40.71K |
Scheduled
|
Dec 1
| ||
Form 4
| -12.03% | -5.70K |
$30.24 | -$172,359.39 | 41.68K |
Scheduled
|
Oct 7
| ||
Form 4
| +14.15% | 5.87K |
—
|
—
| 47.38K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
| -0.55% | -230.00 |
$35.58 | -$8,183.10 | 41.51K |
Scheduled
|
Dec 1
| ||
Form 4
| -12.02% | -5.70K |
$33.10 | -$188,660.31 | 41.73K |
Scheduled
|
Oct 7
| ||
Form 4
| +4.02% | 1.83K |
—
|
—
| 47.44K |
Mar 5
| |||
Form 4
|
∞
| 45.6K |
—
|
—
| 45.6K |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |